{"name":"Kyowa Kirin Pharmaceutical Development Ltd","slug":"kyowa-kirin-pharmaceutical-development-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Granisetron IV","genericName":"Granisetron IV","slug":"granisetron-iv","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Poteligeo","genericName":"Poteligeo","slug":"poteligeo","indication":"Mycosis fungoides","status":"marketed"}]}],"pipeline":[{"name":"Granisetron IV","genericName":"Granisetron IV","slug":"granisetron-iv","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Poteligeo","genericName":"Poteligeo","slug":"poteligeo","phase":"marketed","mechanism":"C-C chemokine receptor type 4","indications":["Mycosis fungoides","Peripheral T-cell lymphoma","Primary cutaneous T-cell lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQb082MFprbTJ4SmVWOTFMU3RRanhUckhQU1RXZ2xDZnZRUUo4NXBrV1d1N0lwaHp2cllrMXNNcXRVY1hjMU5KRDhLb0xkVjllYVcxZFl2eFByM01jS3cxZ2lPWjVFRVYwREVIYWZLLXE5anRUaUNUV1dVTlQxZlh2WGFHYjlrWjRfZmlGV2lzajJqTjRQQjlaUy1BWmNDeWoyX0dKY0xDclB5akYxWmllVHgxblJxa0JSa2Z1RWhPWQ?oc=5","date":"2026-03-06","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC - Fierce Pharma","headline":"Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPR1g1QXJfUlVNY04yYmM1M3lVcXdLN2dnSVBzQmtBV2t6am54REt6S2FnQXBKX3V2eU9uVDIzdXZneUhFeUVNZVc4TTdEM2JuWDc5OHdlWHlGcFJsVFloODljY1ZPdVpKWDQ3XzZCWHNoeHZ2d1ZQWUR3bzNjZU9LdUlPSTlvQ09fdnVBaUZLZzg?oc=5","date":"2026-03-04","type":"pipeline","source":"pharmaphorum","summary":"Cancer risk scuppers Kyowa Kirin's autoimmune disease drug - pharmaphorum","headline":"Cancer risk scuppers Kyowa Kirin's autoimmune disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQdHFCOEd6WUVsdVA0b0NDdEpRTXQzQVpDeV9UbUt2ZmdTM3BBZHNoSkE1RnNYMmVJeWpoUE1LNDZLZW96a0FlRVJ5Z0tUN1o2SFg5UVdIUWFKaEk2WERTRnVSVWxPM0dkSU9QaGQ1em92d24yVWt0MHhVNEN1RzZ5d1dLd1U5eE1uUnlad3hxY1ZJYWM5OHNmdERDRk90b0QwNnZpOXdn?oc=5","date":"2025-12-04","type":"regulatory","source":"San Diego Business Journal","summary":"Kura Oncology Secures FDA Approval of Leukemia Drug - San Diego Business Journal","headline":"Kura Oncology Secures FDA Approval of Leukemia Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPMS1HMXJOQkZRSFBVaGJxcWJmQVVjM1dadlVnSjAzNTBXdW5Tei1KUFNCNUZMc0NBemFtY1VJdjNzUmlXeGpMbmw0eFJzaGx2MFRkQ2l4RElOUGl2MnBPWFhBc2JSYWRuR244SkpTWF9Tdk13NkZtNGxWWEc4cVFESWxZcElqb0hNMUxjMnQ2RlFYYmNIRTA2R0xKZ0lFOS03NGNsZ092Sk4yc0M3VU5LMExldG1oUmVFRHBBZFY2T0dsajZ1?oc=5","date":"2025-04-11","type":"pipeline","source":"Fierce Pharma","summary":"As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan - Fierce Pharma","headline":"As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOZ05nc0Q0YldFem5Fc2I1NGh4WENvRUNlakpoYXIyaEE2TkhCYUk5a1RnYnY3LWdpVWk5bG9PR3RmTHhSeW5zU0V4WDNhQ3U2Wjc1YlJ0ZWREOE1JYl9vMXF0OVkyekc1ZUM0VHVGbllWQlkzVnFzMVU5ZHdwVjdkRzZuNHhFZkIteXNjcEhIalE4TDhkNWtURDNvY3dMcXdmODdhRU0yTlpHRDBYZ3o4?oc=5","date":"2024-11-21","type":"pipeline","source":"Contract Pharma","summary":"Kura & Kyowa Kirin Join Forces to Develop & Commercialize Ziftomenib - Contract Pharma","headline":"Kura & Kyowa Kirin Join Forces to Develop & Commercialize Ziftomenib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQeTZvSWJsUXBXM01IV21VYnlkeWphWG1JdUQ0Z18tc1JjMFFTZi13NzAxVnkya1loNlVfQUpsSWx5NGVqeGdqQUxmSklick1SbGxKSzdPOTdHTDYtOHpJQjhPRHgyYnpteUx5YjFtTTk4bDB4cTk3TjFMTjltcUtCZHdualc3aVhVVTZJek1UREVYVkhsYU9qOU9CVVpWd3UwbjFvNG5kazhMZWVFazdtWUdPQ1dTVV9Ickd3c0l3bw?oc=5","date":"2024-06-14","type":"pipeline","source":"Manufacturing Dive","summary":"Kyowa Kirin will build $530M Research Triangle Park biologics facility - Manufacturing Dive","headline":"Kyowa Kirin will build $530M Research Triangle Park biologics facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPSXRCSm5HcmJiVzA2UmR5V1ZnT3RZZ3Rlci1hUU5uTVlVUVgxck93TUltRHJhWlZHMVRJNmNVMi1CWkhUMktoY05kZDUta3JYVVFiU3NSVGg2U0F6VEhkZjNHcF9SbGQwb2RZMHZ5R1k0WHg4V2ZILUN3NWV2cXY5ZnFZRHdJb0JyWjBsM2Rwd2tlNWdIang4?oc=5","date":"2024-06-14","type":"pipeline","source":"wral.com","summary":"Japanese pharma company to invest up to $530M in Sanford - wral.com","headline":"Japanese pharma company to invest up to $530M in Sanford","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOVkpCNmwwWTVSbmp0V2FsTDh6TzBkVUUtQVdSUU9UZEkxVXN6VmNnc0o5RWtqQ1d2aTUxMlEyQnlrdGNiRFJlNlYzeG4wbm4zQ29uREwzd2lnbTZGcE5MZWxQeHM1Wmw3aHpfMklheTdjTjNudmE4MXIxd1p3VnJFclgwTzgwS2lsR25lS1otN1NwRGhZTVJBM05jYnh2SnppVTl2Vl9KX01HR1BkWjF3a210T0lGRE00ZUdNdUY4SGlJTUotWExXeVhubEI3Q1JzdXlOWWExMkVsOVlpMmdDdnl1UV93Rm5ZWC1PRWRBVll0dw?oc=5","date":"2024-06-10","type":"regulatory","source":"PR Newswire","summary":"Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC - PR Newswire","headline":"Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPRmVjdmhJUkh2cUlmZFF4VUhQd2FTY2NSU2VKN3lPVWFxbEhod0NnYU9Mdy1rTkd2NTJQMDhIbE5zZmtsWS1JYmpoQ0cyOGRick5ZLWp5S0FsRjNRakVGajFzY3VTSVdfUkdYd0w3R0oyeW9TdEJSUXp3RGppYTRXX0tvSDR2d0ZfLXFGMGV3d2F0eTU4ZU5RV0JXLWlHc3AydndmVWgxdVNzN2F6QTlGU2ZicklvdWExcVV5b05YLTByNGhvSTVGVDROc2c?oc=5","date":"2024-04-26","type":"pipeline","source":"Life Science Leader","summary":"Japan-Based Kyowa Kirin To Invest $200 Million For New Pharma Manufacturing Complex In Sanford - Life Science Leader","headline":"Japan-Based Kyowa Kirin To Invest $200 Million For New Pharma Manufacturing Complex In Sanford","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOX0ttbXZIc0ZjQm1taHFKWUFPSEhMUUUybHFvby1qR2VLSEh1dXk0TGVBMTRYNEE5MG9sdS14ZDNGMFZVYTR2bENpUGtTU3RmenlMeEExczNyWnpLRXNaa0hOaTRCQktzM0c1eE4tdjZQNWFnek9CUUlDN3BxV0dnbENIVFpBd0I2N0xJMzJzS29HemstYVV0RU91ckMxWFhXQzFCcDMzUW0?oc=5","date":"2024-02-08","type":"pipeline","source":"BioSpace","summary":"Kyowa Kirin Pays $100M Upfront to BridgeBio for Skeletal Dysplasias Drug in Japan - BioSpace","headline":"Kyowa Kirin Pays $100M Upfront to BridgeBio for Skeletal Dysplasias Drug in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxObmduZHhRZ0tUNmZ1WjNtS0tMRnNlRmpNOUpFUl9RT3c1U3JpTVdrX0ZuSDlJbGw2UWdyNzRvdmJWQ2dnbFlaOGFXWjFrUWkxUmRBSzNnbVVhdy1wbGJfSXhtWkEzS1R3WFVYN05PLWdpcnJ0RWo1X2phanhwV05pcHFhRmxUclBRT3hHRGpFUjFEM0JhY3NrRjJRM194YXFqbUFiYmZQamFZOWtQdi1IZ0lzVUlOV3lVT19jRDYtRVA?oc=5","date":"2023-07-14","type":"pipeline","source":"ROI-NJ","summary":"Japan-based specialty pharma company, Kyowa Kirin, moves into Princeton offices - ROI-NJ","headline":"Japan-based specialty pharma company, Kyowa Kirin, moves into Princeton offices - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOTFU5WVo1YjUzMXZZSDNURVlaeExFY05zY0RONGlSWEFRSGZhZ0NFakRnN2JNUkRSeHVYaExFMkcwaFoxbkt6TDIxRmFGY1hzVkJXMWU3ZDR1ZjVTaHlNTW42RjFyT1RUei1rMm5Ja1VQc2xaR0trQldjX01jd3UtM3NkaDlWQm01eHRTREt2RHJZNmFsZlE?oc=5","date":"2021-06-22","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Regional Power: Japan’s Kyowa Kirin Builds on U.S. Growth - Genetic Engineering and Biotechnology News","headline":"Regional Power: Japan’s Kyowa Kirin Builds on U.S. Growth","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}